What did @brokebestiebudgeting actually say?
The creator is experimenting with injecting above the belly button instead of to the side of it. They said they've "heard that changing up your injection site can change how you feel" but were clear they don't think it changes effectiveness. That's a pretty reasonable, cautious framing for a TikTok about self-injection, and it's worth unpacking whether the science supports any of it.
Notably, they weren't claiming medical expertise. They said "I want to try anything and everything" and invited questions. This is anecdotal sharing, not medical advice, which is an important distinction. Still, millions of people on GLP-1 medications are making injection decisions based on exactly this kind of peer content, so the underlying question deserves a real answer.
Does the science back this up?
Yes, mostly. Injection site does influence absorption rate and, by extension, how patients feel, though the evidence is more nuanced than TikTok tends to make it sound.
A 2021 review in Diabetes, Obesity and Metabolism (Plum-Morschel et al.) confirmed that subcutaneous absorption of injectable medications varies by site, tissue composition, and even local blood flow. Abdominal injections, particularly in the periumbilical region, generally show faster and more consistent absorption compared to the thigh or upper arm for many subcutaneous drugs. However, for semaglutide specifically, the manufacturer's pharmacokinetic data shows relatively low variability across approved abdominal sites. The half-life of semaglutide is roughly seven days, which blunts short-term site-to-site absorption differences considerably compared to shorter-acting drugs like insulin.
What may genuinely differ is local tissue response. Fat distribution, injection depth, and proximity to the umbilicus all affect how the medication disperses into subcutaneous tissue, and that can influence local discomfort or that post-injection sensation some patients describe.
What did they get wrong (or right)?
They got the core distinction right: site rotation probably does not change the drug's effectiveness in any clinically meaningful way for semaglutide. That's accurate. The half-life is long enough that week-to-week site variation is unlikely to produce measurable differences in weight loss outcomes or glycemic control.
Where things get murkier is the implicit suggestion that injecting above versus beside the belly button will produce a noticeably different subjective experience. That's plausible but not well-supported by controlled data specific to semaglutide. Most of what circulates in the GLP-1 community about "better" sites is anecdotal. A 2019 study in Acta Diabetologica (Frid et al.) on injection technique found that lipohypertrophy from repeated injections at the same site can impair absorption, which is actually the strongest evidence-based reason to rotate sites. The creator is accidentally doing the right thing for the right-ish reasons.
The claim that they "can't really feel it" is consistent with what most patients report for the auto-injector pen format, and there's nothing medically concerning about that observation.
What should you actually know?
Site rotation for subcutaneous GLP-1 injections is genuinely recommended, but the reason is less about chasing a better "feel" and more about preventing lipohypertrophy, which is localized fatty tissue buildup from repeated injections in one spot. Frid et al. (2019, Acta Diabetologica) found lipohypertrophy at injection sites correlated with erratic drug absorption over time. Rotating sites prevents that.
Approved injection sites for semaglutide include the abdomen, upper thigh, and upper arm. The prescribing information notes that all three are acceptable. If you're having consistent post-injection symptoms like nausea spikes, it's worth discussing site technique with your prescriber or a diabetes educator, not just crowd-sourcing injection coordinates on TikTok.
- Rotate your injection site each week to prevent lipohypertrophy.
- Avoid injecting within two inches of the belly button, per most clinical guidelines.
- Effectiveness of semaglutide is not meaningfully changed by which approved abdominal quadrant you use.
- If you're noticing consistent discomfort or unusual symptoms at a particular site, tell your prescriber.